Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase 1/2 study evaluating the efficacy and safety of the oral CXCR4 inhibitor X4P-001 in combination with axitinib in patients with advanced renal cell carcinoma.
- Authors
- Vaishampayan, UN[Vaishampayan, Ulka N.]; McDermott, DF[McDermott, David F.]; Matrana, MR[Matrana, Marc Ryan]; Rha, SY[Rha, Sun Young]; Zurita, AJ[Zurita, Amado J.]; Ho, TH[Thai Huu Ho]; Keam, B[Keam, Bhumsuk]; Lee, JL[Lee, Jae-Lyun]; Joseph, RW[Joseph, Richard Wayne]; Ali, S[Ali, Sarah]; Stadler, WM[Stadler, Walter Michael]; Haas, NB[Haas, Naomi B.]; Sundararajan, S[Sundararajan, Srinath]; Park, SH[Park, Se Hoon]; Mowat, RB[Mowat, Rex B.]; Picus, J[Picus, Joel]; Dudek, AZ[Dudek, Arkadiusz Z.]; Zakharia, Y[Zakharia, Yousef]; Gan, L[Gan, Lu]; Atkins, MB[Atkins, Michael B.]
- Issue Date
- 20-May-2018
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.36, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 36
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.